India's Q1 FY27 Growth Leaders: Inside the Concalls of the 20 Fastest-Growing Companies

 India's Q1 FY27 Growth Leaders: Inside the Concalls of the 20 Fastest-Growing Companies

Every quarter, thousands of listed companies report earnings — but only a handful post growth numbers dramatic enough to reshape how the market prices them. This piece looks at 20 companies that posted genuinely strong, durable growth in Q1 FY27 (the quarter ended June 30, 2026), and — more importantly — what management actually said on the concalls about order books, pipelines, and demand that could sustain it.

Why These 20 Companies?

We started from StockScans' "Quarterly Growth Picks" scan (stockscans.in/scans/popular/quarterly+growth+picks), a curated universe of companies flagged for standout quarterly performance across the listed universe, supplemented with a few additional names (Sterlite Technologies, Laurus Labs, Acutaas Chemicals) whose Q1 FY27 results stood out independently. 

From that combined set, we ranked companies on a blend of PAT (profit) growth YoY and revenue growth YoY — a company can show huge profit growth off a tiny, depressed base without much revenue movement, which is a very different story from one growing both lines together. The blend filters for growth that shows up in both the top line and bottom line simultaneously — a stronger signal of durable operating momentum than either metric alone.

The result is a list spanning NBFCs, specialty chemicals, solar manufacturing, transformers, telecom/data-center connectivity, auto and auto components, jewellery retail, pharma/CDMO, and IT services — a genuine cross-section of what's actually working in the Indian economy right now.

  1. Sterlite Technologies (STL)
PAT ~19x YoY | Revenue +87% - The standout story on this list. Consolidated revenue hit a record ₹1,910 crore (+87% YoY), EBITDA nearly tripled to ₹397 crore (+184%), and PAT rose to ₹197 crore from a near-breakeven year-ago quarter. The open order book reached an all-time high of ₹18,618 crore, including a landmark $1.11 billion (₹9,271 crore) award from a global hyperscaler to supply optical connectivity products for AI data centers through FY29. Management raised full-year EBITDA margin guidance to 23% from 20%, and the company completed a ₹1,500 crore QIP that took it to a net debt-free position. Worth noting: the YoY PAT multiple looks extreme partly because last year's base was near breakeven — but unlike the excluded refiners, this is backed by a massive, disclosed, multi-year order book rather than a cyclical margin swing.

  2. Gandhar Oil Refinery
PAT +689% | Revenue +92% - Record quarterly net sales and a record 16.24% operating margin, driven by exports which grew to ₹882 crore — 51% of consolidated revenue — across 100+ countries. Management framed this as a pricing-power story: the company highlighted its ability to pass on base oil cost fluctuations to consumers. Its Texol Lubritech FZC subsidiary in the UAE is now a standalone profit contributor (₹27.3 crore), signalling the international arm is scaling into a genuine second growth engine.

  3. Poonawalla Fincorp
PAT +392% | Revenue +77% - AUM crossed ₹67,000 crore (+11% QoQ, +84% YoY), ROA nearly tripled YoY to 1.98%, and GNPA improved to 1.37%. CEO Arvind Kapil's concall framing: "We did not just launch six businesses, we built six growth engines mounted on a single chassis." The company is explicitly in its "Scale" phase — 2x-ing the consumer durables franchise, expanding gold-loan branches, and deepening AI-led underwriting — backed by the ₹2,500 crore QIP raised in April. New products already contribute 26% of quarterly disbursements.

  4. Hindustan Zinc
PAT +145% | Revenue +72% - CEO Arun Misra: "We have started the year on a strong note with our highest-ever first quarter mined metal production of 268 KT for the fifth consecutive year." Management pointed to ongoing debottlenecking initiatives to lift refined metal output further, plus a previously flagged ₹12,000 crore metals complex and a target of 1.2 MT mined production by FY27. Silver output was cited as an additional earnings kicker.

  5. Laurus Labs
PAT +125% | Revenue +29% - Best quarter in company history: revenue of ₹2,026 crore (+29% YoY, +12% QoQ), EBITDA up 67% to ₹644 crore, margin expanding to 31.8% from 24.8%. Growth was driven by a 67% surge in CDMO revenue as late-stage clinical and commercial programs scaled. CEO Dr. Satyanarayana Chava: the quarter reflected "record quarterly Revenue with expanded profitability." Management raised FY27 capex guidance from ₹1,000 crore to ₹2,000 crore specifically to expand capacity for existing customer demand across API, formulations, peptides, fermentation, and antibody-drug-conjugate technologies — over 85% of that capex is going toward diversifying beyond its legacy ARV-API base, backed by "a healthy order book, internal pipeline, and key customer relationships." A new Vizag fermentation facility is due online by Q3 FY27.

  6. Fineotex Chemical
PAT +93% | Revenue +175% - Revenue nearly tripled on the back of the newly integrated CrudeChem Technologies (US oilfield specialty chemicals) acquisition. CFO Sanjay Tibrewala: "We delivered a strong start to FY27 with healthy growth in both revenues and profitability, supported by the successful integration of our oilfield specialty chemicals business." The company commissioned a major Texas capacity expansion (total capacity now ~148,000 MTPA) and continues to evaluate further inorganic growth opportunities across textile, water treatment, FMCG, and cleaning & hygiene.

  7. SG Finserve
PAT +119% | Revenue +102% - Record loan book of ₹4,552 crore, up 82% YoY. Management guided to FY27 PBT of ~₹300 crore (75% YoY growth) and an AUM target of ₹5,500 crore for FY27, scaling to ₹10,000 crore by FY30 — without needing fresh equity up to that point. Near-term pipeline items include commercialising Factoring and TReDS solutions and a feasibility study for a GIFT City finance company.

  8. Oracle Financial Services Software (OFSS)
PAT +121% | Revenue +69% - Product license revenue drove the beat (up 75% YoY), with EBIT margin expanding to 59.6%. The quarter came bundled with a leadership transition — CFO Avadhut Ketkar stepping up to MD & CEO. On demand: management flagged that one of the largest vacation-ownership companies in the US signed on for OFSS's lending and leasing cloud software during the quarter — a concrete new-logo win supporting the broader cloud-banking demand narrative.

  9. Navkar Corporation
PAT +401% | Revenue +38% - Now under JSW Infrastructure's ownership, Navkar's logistics segment revenue jumped to ₹237 crore from ₹138 crore YoY, with segment EBITDA more than tripling. Parent JSW Infrastructure's own concall framed the integration as delivering "strong operational synergy," part of a broader ₹30,000 crore capex plan to reach 400 MTPA cargo capacity by FY2030.

  10. DP Abhushan
PAT +77% | Revenue +58% - EBITDA grew 70% YoY as the jewellery retailer's wedding-season demand (60% of FY26 product mix) continued. Concrete pipeline items: new showrooms opened/approved in Dahod (Gujarat, company-owned) and Jabalpur (franchisee-owned), alongside the launch of the "DP Swan Plus" gold-price-protection program. Management's stated target is 20 stores by FY28.

  11. Emmvee Photovoltaic Power
PAT +103% | Revenue +51% - Chairman DV Manjunatha: "This is the strongest first quarter in Emmvee's history, with both production volumes and margins at all-time-high... Our strong order book, the implementation of ALMM List II and our on-track 6 GW integrated expansion give us confidence as we enter the next phase of India's solar manufacturing growth." Order book at an all-time high of ~9.9 GW, solar cell utilisation at a record 83%, and a ₹5,500 crore expansion plan targeting 16.3 GW of module capacity by early FY28.

  12. Sakar Healthcare
PAT +120% | Revenue +38% - A smaller pharma name mid-transition from contract manufacturer to a research-driven, export-oriented oncology player. Management has flagged FY27 as "a pivotal year," driven by scaling of its oncology parenteral unit and a substantial increase in export volumes to regulated markets — oncology already contributed ~38% of FY26 revenue, with export contribution targeted above 45–50% of revenue by FY27.

  13. WPIL Ltd
PAT +129% | Revenue +32% - A pumps and water-infrastructure player entering FY27 on "a positive outlook, backed by a strong order book and renewed momentum under Jal Jeevan Mission Phase 2." The product division showed healthy order inflows across power, industrial, and water end-markets, though the domestic project business (subject to government fund-release timing) remains the swing factor to watch.

  14. TVS Holdings
PAT +74–82% | Revenue +34% - The holding company for TVS Motor (record 16.31 lakh units sold, +32% YoY) and TVS Credit's financial services arm. The key pipeline item outside the core two-wheeler volume story: TVS Holdings' financial-services subsidiary, Home Credit India, is acquiring Varthana Finance for ₹967 crore, positioning for expansion into longer-tenure, secured retail lending.

  15. SRF Ltd
PAT +76% | Revenue +32% - A record quarter across the board: Performance Films & Foil profit jumped 149% on record packed-film production, and Chemicals (fluoropolymers, refrigerants, chloromethanes) grew 26%. The board approved a fresh ₹250 crore investment in a new BOPET thick-film line, on top of a previously announced new HFO plant in Odisha (commissioning by February 2028). Standing guidance is for 15–20% growth in the Chemicals business through FY27, though management flagged continued pricing pressure from Chinese competition.

  16. Atlanta Electricals
PAT +50% | Revenue +48% - One of the clearest order-book disclosures on this list. Chairman & MD Niral Patel: "Our order book increased 25.0% sequentially to ₹3,116.63 crore, providing strong revenue visibility and reaffirming the robust demand environment across transmission & distribution, renewable energy and industrial applications." The company won a ₹291.68 crore order from Rajasthan's RRVPNL during the quarter and now has more than 55% of its order book in 220kV-and-above transformers, backed by PGCIL approval to manufacture 400kV-class transformers at its Vadod facility.

  17. Jayaswal Neco Industries
PAT +108% | Revenue +28% - Highest-ever quarterly operating profit (₹396 crore) for this iron/steel castings and alloy steel manufacturer, with PAT margin expanding to 9.2% from 5.6%. Revenue growth (28% YoY) came with real volume momentum in castings and alloy steel for automotive and industrial OEMs. Runway: a new 1.50 MnTPA pellet plant in Raipur, backward-integrating the company's steel value chain.

  18. Apar Industries
PAT +78% | Revenue +29% - All three verticals (conductors, cables, transformer oil) grew steadily; total income up 29% to ₹6,625 crore. Management's Q4 FY26 call had already flagged the US data-center opportunity as a structural driver for premium conductors — this quarter's results (conductor revenue +20% YoY, transformer/speciality oil +35% YoY) show that continuing to play out. Runway: a ₹1,500 crore FY27 capex plan and a new UK subsidiary to chase further export demand.

  19. Bajaj Auto
PAT +44–46% | Revenue +37–65% - Record quarterly volumes, revenue (₹17,244 crore, all-time high) and profit, driven by strong domestic demand, record export volumes (732,000 units, 40% of revenue, with share gains in Nigeria and Mexico), and an accelerating EV mix — electric 2- and 3-wheelers now account for 30% of domestic revenue at double-digit EBITDA margins, with the Chetak scooter moving from EBITDA-neutral to EBITDA-positive. Management also committed to a 100% payout ratio via a hybrid dividend-plus-buyback structure.

  20. Acutaas Chemicals
PAT +70% | Revenue +59% - Revenue of ₹329.7 crore (+59.1% YoY), EBITDA more than doubling to ₹113.1 crore, margin expanding by ~973bps to 34.3%. Growth was broad-based across pharmaceutical intermediates/CDMO and early commercial traction in newer specialty lines. Notably, battery chemicals began commercial supply during the quarter, with management calling demand "unprecedented," and the company's CDMO pipeline has four additional validated products awaiting regulatory approval, each with potential peak revenue of ₹50–100 crore. Chairman Naresh Patel also flagged that the team navigated Gulf-region geopolitical supply disruption without production impact. Management guides to 25–28% full-year revenue growth for FY27.


Excluded: A Note on Base-Effect and Accounting-Artifact Growth

Two names — Ador Welding (PAT +799%, revenue +23%) and Mahindra Lifespace Developers (PAT +67%, revenue +2,909%) — posted growth large enough to rank near the top of this list on pure percentage terms, but we've kept them out of the ranked 20 above because the headline number needs an important caveat:

Ador Welding swung from a net loss in Q1 FY26 to ₹27.6 crore profit — a genuine operational turnaround, but one management itself has attributed to the completion of a large, lumpy ONGC Uran Flares project. Management's own commentary points to FY27 as the year core-business profitability becomes visible without project-business noise, meaning this quarter's percentage growth is arithmetic against a loss-making base rather than yet a clean read on the underlying welding-equipment business.

Mahindra Lifespace's revenue number is a project-completion-accounting artifact under Ind AS 115, not organic demand growth. The real pipeline signal is in bookings, not revenue: CEO Amit Kumar Sinha noted the company added ₹5,600 crore of GDV in the Mumbai region alone this quarter, building on two consecutive years of 18,000+ crore in GDV additions — that's the number worth tracking for this stock, not the reported revenue line.

We've also left out Chennai Petroleum Corporation and Mangalore Refinery (MRPL) entirely: both companies swung from Q1 FY26 refining losses to Q1 FY27 profits purely on the back of a cyclical gross-refining-margin bounce, with no meaningful order-book, pipeline, or demand commentary underpinning the number.

What to Track as Concall Season Continues

A few patterns worth carrying forward as more Q1 FY27 results and calls land over the coming weeks:

1. Separate the base-effect stories from the structural ones — always check the QoQ trend, not just YoY. A loss-making or unusually weak year-ago quarter can produce an enormous YoY percentage that says very little about current momentum.
2. Order book disclosures are the highest-signal data point when companies give them. Sterlite Technologies (₹18,618 crore, including a $1.1B AI data-center deal), Atlanta Electricals (₹3,117 crore, +25% QoQ), Emmvee (9.9 GW, all-time high), and SG Finserve's explicit forward guidance are the most trackable, quantified visibility in this list. Where a company doesn't disclose an order book (most NBFCs, pharma names), watch disbursement/volume trends and management's qualitative demand commentary instead.
3. Watch capex-to-revenue conversion timelines. Several names here (Emmvee's 6 GW expansion, SRF's Odisha HFO plant, Apar's data-center-driven conductor capex, Jayaswal Neco's pellet plant, Laurus's ₹2,000 crore capex step-up) are pre-revenue or in-progress capacity bets. The next 2–4 quarters of concalls should start showing whether utilisation and order inflows are keeping pace with the new capacity coming online.
4. M&A as a growth lever is showing up repeatedly. Fineotex (CrudeChem), TVS Holdings/Home Credit (Varthana Finance), and Acutaas (Indichem semiconductor JV) are all leaning on acquisitions to accelerate growth beyond organic capacity — worth tracking integration progress in subsequent quarters, not just the initial deal announcement.
5. AI/data-center-linked capex is now a real, disclosed demand driver in Indian industrials — not just an IT-services story. Sterlite Technologies' $1.1B hyperscaler contract and Apar Industries' US data-center conductor demand are two concrete, quantified examples this quarter; worth watching which other industrial names start disclosing similar order flow.

If you want to build your own version of this screen, StockScans' Quarterly Growth Picks scan lets you filter and re-rank the universe by PAT growth, revenue growth, or other criteria as fresh results land through the rest of the July–August 2026 earnings season — a useful way to catch the next names that make a list like this one before the crowd does, and to spot base-effect distortions yourself by cross-checking QoQ trends alongside YoY.

Disclaimer: The information provided on Shuchi Nahar’s Weekend Blog is for educational purposes only. I am not SEBI Registered please ask your investment advisor before taking any actions. The articles may contain external links, references, and a compilation of various publicly available articles. Hence all the authors are given due credit for the same. All copyrights and trademarks of images belong to their respective owners and are used for Fair Educational purposes only.